CLL NAVIGATOR Trademark
CLL NAVIGATOR is a USPTO trademark filed by BEONE MEDICINES I GMBH. Status: Pending.
Trademark Facts
| Mark | CLL NAVIGATOR |
|---|---|
| Serial Number | 99606503 |
| Status | Pending |
| Filing Date | 2026-01-21 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 035 (Advertising & Business), 041 (Education & Entertainment), 042 (Software & IT) |
| Owner | BEONE MEDICINES I GMBH |
| Attorney of Record | Kristen Ruisi |
| Prosecution Events | 24 |
| Latest Event | PUBO on 2026-05-05 |
Goods & Services
Class 009: Downloadable mobile application for providing medical information related to healthcare namely, cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; downloadable computer software for providing medical information related to healthcare namely, cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; downloadable software for enabling patients to request, receive, and manage prescriptions and orders of the pharmaceuticals and over the counter medicated preparations; Class 035: Retail pharmacy services; mail order pharmacy services; online retail pharmacy services; pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Class 041: Educational services, namely, providing a website featuring blogs and non-downloadable publications in the nature of informational articles and guides in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Educational services, namely, providing on-line newsletters in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Providing online non-downloadable videos in the fields of cancer, autoimmune and inflammatory disease, rheumatoid arthritis, cardiovascular diseases and infectious diseases; Class 042: Research and development of new products for others; technological research in the field of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; chemical research; scientific research in the nature of conducting clinical trials for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; biological research; quality control of goods and services for others for the treatment of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; electronic data storage; material testing; cloud computing featuring software for use in database management, word processing, spreadsheet management, tracking
Recent Prosecution Activity
| Date | Document | Type |
|---|---|---|
| 2026-04-07 | Response to Office Action | ROA |
| 2026-04-02 | Non-Final Action | NFIN |
| 2026-04-02 | Notice of Non-Final Office Action | NFO |
| 2026-03-25 | Response to Office Action | ROA |
| 2026-03-22 | Non-Final Action | NFIN |
| 2026-03-22 | Notice of Non-Final Office Action | NFO |
USPTO Refusals on Record
- disclaimer_required
- indefinite_identification
- multiple_class_application